Benevolent AI uses technology to speed up medical discovery by analysing large scientific research data sets to create its own insights.

Based in London, with offices in Cambridge, New York and Antwerp, the business aims to accelerate the journey from data to medicine and is collaborating with AstraZeneca to discover new drugs for kidney disease.

Back to BusinessCloud's 101 HealthTech Innovators